Robert Stein is a highly experienced leader in biotech and pharmaceutical R&D, with over 40 years in the field. They served as EVP of Research & Development at Mimedx from 2019 to 2022 and held various leadership roles at prominent companies such as Incyte, DuPont-Merck Pharmaceuticals, and Roche Palo Alto. Currently, Stein is the Senior R&D Advisor & Founder at MiNK Therapeutics and serves on multiple boards, including Taro Pharmaceutical Industries and Isosceles Pharmaceuticals. They earned an M.D.-Ph.D. in Physiology & Pharmacology from Duke University and a B.S. in Biology & Chemistry from Indiana University Bloomington.
Location
New York, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices